Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation
暂无分享,去创建一个
[1] E. Brown,et al. Is the calcium receptor a molecular target for the actions of strontium on bone? , 2003, Osteoporosis International.
[2] C. Christiansen,et al. Incorporation and distribution of strontium in bone. , 2001, Bone.
[3] R. Rizzoli,et al. A comprehensive review of treatments for postmenopausal osteoporosis , 2003, Osteoporosis International.
[4] R. Baron,et al. Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. , 2005, Bone.
[5] G. Dalsky,et al. Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] T. Spector,et al. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004, The New England journal of medicine.
[7] P. Marie,et al. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. , 1996, Bone.
[8] M. Ruat,et al. In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor. , 2004, Biochemical and biophysical research communications.
[9] P. Marie,et al. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. , 2004, Metabolism: clinical and experimental.
[10] P. Meunier,et al. Long‐Term Strontium Ranelate Administration in Monkeys Preserves Characteristics of Bone Mineral Crystals and Degree of Mineralization of Bone , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] P. Marie,et al. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. , 2002, Metabolism: clinical and experimental.
[12] P. Marie,et al. Short-term effects of fluoride and strontium on bone formation and resorption in the mouse. , 1986, Metabolism: clinical and experimental.
[13] P. Marie. Strontium ranelate: a novel mode of action optimizing bone formation and resorption , 2004, Osteoporosis International.
[14] P. Marie,et al. Effects of low doses of strontium on bone quality and quantity in rats. , 1990, Bone.
[15] L. Quarles,et al. A Novel Cation‐Sensing Mechanism in Osteoblasts Is a Molecular Target for Strontium , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] L. Quarles,et al. Identification of a Novel Extracellular Cation-sensing G-protein-coupled Receptor* , 2005, Journal of Biological Chemistry.
[17] P. Chappuis,et al. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). , 2001, Bone.
[18] P. Marie,et al. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen‐deficient rats , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] P. Meunier,et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] R. Baron,et al. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. , 2002, European journal of pharmacology.
[21] E. Seeman. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis , 2003, Osteoporosis International.
[22] P. Marie,et al. S12911-2 reduces bone loss induced by short-term immobilization in rats. , 2003, Bone.
[23] P. Marie,et al. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. , 1996, Bone.
[24] R. Rizzoli,et al. Strontium Ranelate Improves Bone Resistance by Increasing Bone Mass and Improving Architecture in Intact Female Rats , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[25] N. Takahashi,et al. S 12911‐2 Inhibits Osteoclastic Bone Resorption In Vitro , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[27] T. Martin,et al. Therapeutic approaches to bone diseases. , 2000, Science.
[28] P. Marie,et al. Effect of low doses of stable strontium on bone metabolism in rats. , 1985, Mineral and electrolyte metabolism.